RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Kim Kline to Tumor Cells, Cultured

This is a "connection" page, showing publications Kim Kline has written about Tumor Cells, Cultured.
Connection Strength

0.865
  1. Tiwary R, Yu W, Sanders BG, Kline K. a-TEA cooperates with MEK or mTOR inhibitors to induce apoptosis via targeting IRS/PI3K pathways. Br J Cancer. 2011 Jan 04; 104(1):101-9.
    View in: PubMed
    Score: 0.086
  2. Kline K, Cochran GS, Sanders BG. Growth-inhibitory effects of vitamin E succinate on retrovirus-transformed tumor cells in vitro. Nutr Cancer. 1990; 14(1):27-41.
    View in: PubMed
    Score: 0.081
  3. Yu W, Shun MC, Anderson K, Chen H, Sanders BG, Kline K. alpha-TEA inhibits survival and enhances death pathways in cisplatin sensitive and resistant human ovarian cancer cells. Apoptosis. 2006 Oct; 11(10):1813-23.
    View in: PubMed
    Score: 0.065
  4. Yu W, Sanders BG, Kline K. RRR-alpha-tocopheryl succinate-induced apoptosis of human breast cancer cells involves Bax translocation to mitochondria. Cancer Res. 2003 May 15; 63(10):2483-91.
    View in: PubMed
    Score: 0.051
  5. Lawson KA, Anderson K, Menchaca M, Atkinson J, Sun L, Knight V, Gilbert BE, Conti C, Sanders BG, Kline K. Novel vitamin E analogue decreases syngeneic mouse mammary tumor burden and reduces lung metastasis. Mol Cancer Ther. 2003 May; 2(5):437-44.
    View in: PubMed
    Score: 0.051
  6. You H, Yu W, Munoz-Medellin D, Brown PH, Sanders BG, Kline K. Role of extracellular signal-regulated kinase pathway in RRR-alpha-tocopheryl succinate-induced differentiation of human MDA-MB-435 breast cancer cells. Mol Carcinog. 2002 Apr; 33(4):228-36.
    View in: PubMed
    Score: 0.047
  7. Yu W, Sanders BG, Kline K. RRR-alpha-tocopheryl succinate induction of DNA synthesis arrest of human MDA-MB-435 cells involves TGF-beta-independent activation of p21Waf1/Cip1. Nutr Cancer. 2002; 43(2):227-36.
    View in: PubMed
    Score: 0.047
  8. Yu W, Liao QY, Hantash FM, Sanders BG, Kline K. Activation of extracellular signal-regulated kinase and c-Jun-NH(2)-terminal kinase but not p38 mitogen-activated protein kinases is required for RRR-alpha-tocopheryl succinate-induced apoptosis of human breast cancer cells. Cancer Res. 2001 Sep 01; 61(17):6569-76.
    View in: PubMed
    Score: 0.046
  9. Yu W, Israel K, Liao QY, Aldaz CM, Sanders BG, Kline K. Vitamin E succinate (VES) induces Fas sensitivity in human breast cancer cells: role for Mr 43,000 Fas in VES-triggered apoptosis. Cancer Res. 1999 Feb 15; 59(4):953-61.
    View in: PubMed
    Score: 0.038
  10. Herbert BS, Sanders BG, Kline K. N-(4-hydroxyphenyl)retinamide activation of transforming growth factor-beta and induction of apoptosis in human breast cancer cells. Nutr Cancer. 1999; 34(2):121-32.
    View in: PubMed
    Score: 0.038
  11. Yu W, Simmons-Menchaca M, You H, Brown P, Birrer MJ, Sanders BG, Kline K. RRR-alpha-tocopheryl succinate induction of prolonged activation of c-jun amino-terminal kinase and c-jun during induction of apoptosis in human MDA-MB-435 breast cancer cells. Mol Carcinog. 1998 Aug; 22(4):247-57.
    View in: PubMed
    Score: 0.037
  12. Zhao B, Yu W, Qian M, Simmons-Menchaca M, Brown P, Birrer MJ, Sanders BG, Kline K. Involvement of activator protein-1 (AP-1) in induction of apoptosis by vitamin E succinate in human breast cancer cells. Mol Carcinog. 1997 Jul; 19(3):180-90.
    View in: PubMed
    Score: 0.034
  13. Yu W, Sanders BG, Kline K. RRR-alpha-tocopheryl succinate inhibits EL4 thymic lymphoma cell growth by inducing apoptosis and DNA synthesis arrest. Nutr Cancer. 1997; 27(1):92-101.
    View in: PubMed
    Score: 0.033
  14. Yu W, Heim K, Qian M, Simmons-Menchaca M, Sanders BG, Kline K. Evidence for role of transforming growth factor-beta in RRR-alpha-tocopheryl succinate-induced apoptosis of human MDA-MB-435 breast cancer cells. Nutr Cancer. 1997; 27(3):267-78.
    View in: PubMed
    Score: 0.033
  15. Yu W, Sanders BG, Kline K. Modulation of murine EL-4 thymic lymphoma cell proliferation and cytokine production by vitamin E succinate. Nutr Cancer. 1996; 25(2):137-49.
    View in: PubMed
    Score: 0.031
  16. Charpentier A, Simmons-Menchaca M, Yu W, Zhao B, Qian M, Heim K, Sanders BG, Kline K. RRR-alpha-tocopheryl succinate enhances TGF-beta 1, -beta 2, and -beta 3 and TGF-beta R-II expression by human MDA-MB-435 breast cancer cells. Nutr Cancer. 1996; 26(2):237-50.
    View in: PubMed
    Score: 0.031
  17. Sanders BG, Kline K. Nutrition, immunology and cancer: an overview. Adv Exp Med Biol. 1995; 369:185-94.
    View in: PubMed
    Score: 0.029
  18. Turley JM, Sanders BG, Kline K. Vitamin E succinate induction of HL-60 cell adhesion: a role for fibronectin and a 72-kDa fibronectin-binding molecule. Nutr Cancer. 1995; 23(1):43-54.
    View in: PubMed
    Score: 0.029
  19. Charpentier A, Groves S, Simmons-Menchaca M, Turley J, Zhao B, Sanders BG, Kline K. RRR-alpha-tocopheryl succinate inhibits proliferation and enhances secretion of transforming growth factor-beta (TGF-beta) by human breast cancer cells. Nutr Cancer. 1993; 19(3):225-39.
    View in: PubMed
    Score: 0.025
  20. Turley JM, Sanders BG, Kline K. RRR-alpha-tocopheryl succinate modulation of human promyelocytic leukemia (HL-60) cell proliferation and differentiation. Nutr Cancer. 1992; 18(3):201-13.
    View in: PubMed
    Score: 0.023
  21. Speck P, Kline KA, Cheresh P, Longnecker R. Epstein-Barr virus lacking latent membrane protein 2 immortalizes B cells with efficiency indistinguishable from that of wild-type virus. J Gen Virol. 1999 Aug; 80 ( Pt 8):2193-2203.
    View in: PubMed
    Score: 0.010
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support